Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion type Assertion NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_head.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion description "[These results were further supported by the CART analysis which revealed that individuals with the combined genotypes of ESR1-397 CT or TT, ESR1-351 AG or GG and ESR2 -789 AA had the highest risk for GBC [OR = 3.9].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_provenance.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion evidence source_evidence_literature NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_provenance.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion SIO_000772 22808109 NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_provenance.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion wasDerivedFrom befree-20140225 NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_provenance.
- NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_assertion wasGeneratedBy ECO_0000203 NP183581.RAsK1Zu1B0SSSiD5uakOGEzV3mWMDyR3Sl5027uww2ywU130_provenance.